Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.24.0.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME (LOSS) BEFORE INCOME TAX (BENEFIT) EXPENSE

The components of income (loss) before income tax expense (benefit) by jurisdiction for continuing operations for the years ended December 31, consisted of the following (in thousands):

 

    2023     2022  
United States     622       (2,782 )
Canada     521       (630 )
United Kingdom     (208 )     (177 )
Total income (loss) before tax benefit   $ 935     $ (3,589 )
SCHEDULE OF COMPONENTS OF INCOME TAX (BENEFIT) EXPENSE

The components of current and deferred federal and state income tax expense (benefit) for continuing operations for the years ended December 31, consisted of the following (in thousands):

 

    2023     2022  
Federal income tax expense - current     76        
Federal income tax benefit - deferred     (28 )     (331 )
State income tax expense - current     7       12  
State income tax benefit - deferred     (38 )     (59 )
Total income tax expense (benefit)   $ 17     $ (378 )
SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION

An overall reconciliation between the expected tax expense (benefit) using the federal statutory rate of 21% for each of the years ended 2023 and 2022 and the expense (benefit) for income taxes from continuing operations as reported in the accompanying Consolidated Statement of Operations is provided below (in thousands).

 

                 
    2023     2022  
Federal tax expense (benefit) at statutory rate   $ 196     $ (754 )
State tax expense, net of federal benefit     50       5  
Difference in foreign rate     20       (42 )
Permanent items     116       133  
Change in deferred tax rates     51       20  
Reserve for uncertain tax positions     81        
Tax credits     (318 )      
Stock-based compensation     100       93  
Provision-to-return adjustments     155       52  
Other           5  
(Decrease) increase in valuation allowance     (434 )     110  
Income tax expense (benefit)   $ 17     $ (378 )
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The Company had temporary differences and net operating loss carry forwards from both our continuing and discontinued operations, which gave rise to deferred tax assets as of December 31, 2023, and 2022 as follows (in thousands):

 

    2023     2022  
Deferred tax assets:                
Net operating losses   $ 9,876     $ 11,646  
Environmental and closure reserves     2,332       2,269  
Lease liability     525       482  
Capital loss carryforward     780       756  
Accrued expenses     1,186       776  
R&D cost capitalization     905       25  
Tax credits     200       135  
Deferred tax liabilities:                
Depreciation and amortization     (4,260 )     (4,351 )
Indefinite lived intangible assets     (557 )     (503 )
Right-of-use lease asset     (510 )     (476 )
481(a) adjustment           (53 )
Prepaid expenses     (46 )     (30 )
Deferred tax assets, gross      10,431       10,676  
Valuation allowance     (6,131 )     (6,560 )
Net deferred income tax asset     4,300       4,116  
SCHEDULE OF RECOGNIZED TAX EXPENSES

The Company accounts for uncertainties in income tax pursuant to ASC 740. A reconciliation of the beginning and ending amount of our recognized tax expense is summarized as follows (in thousands):

    2023     2022  
Balances at beginning of year   $     $  
Addition related to R&D tax credit     81        
Balances at end of the year   $ 81     $